Search - tctmd.com

Displaying 1 - 20 of 47

Sort: Relevancy | Date

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

News Conference News EuroPCR 2024

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Caitlin E. Cox

May 24, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

Caitlin E. Cox

May 20, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

Michael O'Riordan

May 17, 2024

News Conference News EuroPCR 2024

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

Yael L. Maxwell

May 16, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Shelley Wood

May 16, 2024

News Conference News EuroPCR 2024

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

Michael O'Riordan

May 15, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

Presentation EuroPCR 2024

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Presenter: Eliano Navarese

May 15, 2024

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Presentation EuroPCR 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presenter: Mateusz Tajstra

May 15, 2024

Presentation EuroPCR 2024

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

Presenter: Ole De Backer

May 15, 2024

Presentation EuroPCR 2024

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Presenter: Danny Dvir

May 15, 2024

Presentation EuroPCR 2024

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Presenter: Patrick Serruys

May 15, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Conference News EuroPCR 2024

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Caitlin E. Cox

May 15, 2024

Advertisement

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Coronary Access More Challenging With Self-Expanding Valves: SCAAR/SWENTRY

SWIFT TAVI Algorithm Lowers Wait Times for Highest-Risk Patients

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2

First report of an IDE pivotal study of a dedicated splitting device during TAVR

Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

ORBITA-2: Angina Phenotype Strongly Predicts PCI Response

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content